127 related articles for article (PubMed ID: 7491121)
1. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents.
Yen L; Woo A; Christopoulopoulos G; Batist G; Panasci L; Roy R; Mitra S; Alaoui-Jamali MA
Mutat Res; 1995 Nov; 337(3):179-89. PubMed ID: 7491121
[TBL] [Abstract][Full Text] [Related]
2. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
Damia G; Imperatori L; Stefanini M; D'Incalci M
Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.
Damia G; Guidi G; D'Incalci M
Eur J Cancer; 1998 Oct; 34(11):1783-8. PubMed ID: 9893669
[TBL] [Abstract][Full Text] [Related]
5. Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.
Alaoui-Jamali M; Loubaba BB; Robyn S; Tapiero H; Batist G
Cancer Chemother Pharmacol; 1994; 34(2):153-8. PubMed ID: 8194166
[TBL] [Abstract][Full Text] [Related]
6. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
7. Modulation of melphalan and cisplatin cytotoxicity in human ovarian cancer cells resistant to alkylating drugs.
Gornati D; Zaffaroni N; Villa R; De Marco C; Silvestrini R
Anticancer Drugs; 1997 Jun; 8(5):509-16. PubMed ID: 9215615
[TBL] [Abstract][Full Text] [Related]
8. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
9. Enhancing alkylating agent resistance through ERCC2 gene transfection in human glioma cell line.
Chen Z; Zhang J; Mohr G
Chin Med J (Engl); 2003 Aug; 116(8):1171-4. PubMed ID: 12935404
[TBL] [Abstract][Full Text] [Related]
10. Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).
Dong Q; Johnson SP; Colvin OM; Bullock N; Kilborn C; Runyon G; Sullivan DM; Easton J; Bigner DD; Nahta R; Marks J; Modrich P; Friedman HS
Cancer Chemother Pharmacol; 1999; 43(1):73-9. PubMed ID: 9923544
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
[TBL] [Abstract][Full Text] [Related]
12. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
[TBL] [Abstract][Full Text] [Related]
13. Enhanced DNA excision repair in CCRF-CEM cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea, quantitated using the single cell gel electrophoresis (Comet) assay.
Yamauchi T; Kawai Y; Ueda T
Biochem Pharmacol; 2003 Sep; 66(6):939-46. PubMed ID: 12963480
[TBL] [Abstract][Full Text] [Related]
14. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
Zeng-Rong N; Paterson J; Alpert L; Tsao MS; Viallet J; Alaoui-Jamali MA
Cancer Res; 1995 Nov; 55(21):4760-4. PubMed ID: 7585500
[TBL] [Abstract][Full Text] [Related]
15. Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.
Grombacher T; Mitra S; Kaina B
Carcinogenesis; 1996 Nov; 17(11):2329-36. PubMed ID: 8968045
[TBL] [Abstract][Full Text] [Related]
16. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes.
Vogel U; Dybdahl M; Frentz G; Nexo BA
Mutat Res; 2000 Nov; 461(3):197-210. PubMed ID: 11056291
[TBL] [Abstract][Full Text] [Related]
17. Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid.
Caffrey PB; Zhu M; Zhang Y; Chinen N; Frenkel GD
Cancer Lett; 1999 Feb; 136(1):47-52. PubMed ID: 10211938
[TBL] [Abstract][Full Text] [Related]
18. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
Wu X; Fan W; Xu S; Zhou Y
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5874-9. PubMed ID: 14676109
[TBL] [Abstract][Full Text] [Related]
19. In vitro evidence for homologous recombinational repair in resistance to melphalan.
Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
[TBL] [Abstract][Full Text] [Related]
20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
